• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鞘脂类贮积病:概述

The sphiningolipidoses: an overview.

作者信息

West H H

出版信息

Postgrad Med. 1977 Mar;61(3):90-3, 95. doi: 10.1080/00325481.1977.11712151.

DOI:10.1080/00325481.1977.11712151
PMID:402652
Abstract

An outline of the pathways of catabolism of four sphingolipids to ceramide, along with structural details of a few constituents, serves as a framework for better understanding of the sphingolipidoses. The four sphingolipids are sulfatide, sphingomyelin, globoside, and ganglioside GM1. Diseases which can be incorporated into the scheme include Niemann-Pick disease, Gaucher disease, metachromatic leukodystrophy, Krabbe disease, ceramide lactoside lipidosis, Tay-Sachs disease, generalized gangliosidosis, Fabry disease, and Sandhoff disease. Fucosidosis probably also belongs with this group. GM3 (hematoside) sphingolipodystrophy involves blocks in synthetic rather than catabolic pathways.

摘要

四种鞘脂分解代谢生成神经酰胺的途径概述,以及一些成分的结构细节,为更好地理解鞘脂贮积病提供了一个框架。这四种鞘脂分别是硫脂、鞘磷脂、红细胞糖苷脂和神经节苷脂GM1。可纳入该方案的疾病包括尼曼-匹克病、戈谢病、异染性脑白质营养不良、克拉伯病、神经酰胺乳糖苷脂沉积症、泰-萨克斯病、全身性神经节苷脂沉积症、法布里病和桑德霍夫病。岩藻糖苷贮积症可能也属于这一组。GM3(血苷)鞘脂营养不良涉及合成途径而非分解代谢途径的阻断。

相似文献

1
The sphiningolipidoses: an overview.鞘脂类贮积病:概述
Postgrad Med. 1977 Mar;61(3):90-3, 95. doi: 10.1080/00325481.1977.11712151.
2
Concentrations of an activator protein for sphingolipid hydrolysis in liver and brain samples from patients with lysosomal storage diseases.溶酶体贮积病患者肝脏和脑样本中鞘脂水解激活蛋白的浓度。
J Clin Invest. 1983 Nov;72(5):1622-8. doi: 10.1172/JCI111121.
3
Gene Therapy of Sphingolipid Metabolic Disorders.鞘脂代谢障碍的基因治疗。
Int J Mol Sci. 2023 Feb 11;24(4):3627. doi: 10.3390/ijms24043627.
4
Basic findings and current developments in sphingolipidoses.鞘脂贮积病的基本研究结果与当前进展
Hum Genet. 1979 Mar 12;47(2):113-34. doi: 10.1007/BF00273194.
5
Sphingolipidoses in Turkey.土耳其的鞘脂贮积症。
Brain Dev. 2004 Sep;26(6):363-6. doi: 10.1016/j.braindev.2003.09.006.
6
Accumulation of lysosphingolipids in tissues from patients with GM1 and GM2 gangliosidoses.GM1和GM2神经节苷脂贮积症患者组织中溶血鞘脂的蓄积。
J Neurochem. 1992 Oct;59(4):1452-8. doi: 10.1111/j.1471-4159.1992.tb08460.x.
7
[Activator protein for the enzymic hydrolysis of sphingolipids and their relationships to sphingolipidosis. Special reference to the catabolism of GM2 ganglioside].[鞘脂酶促水解的激活蛋白及其与鞘脂贮积症的关系。特别提及GM2神经节苷脂的分解代谢]
Seikagaku. 1983;55(1):1-13.
8
Sphingolipid metabolism in neural tissues.神经组织中的鞘脂代谢
Neurosci Res (N Y). 1969;2(0):301-15.
9
Application of delayed extraction matrix-assisted laser desorption ionization time-of-flight mass spectrometry for analysis of sphingolipids in cultured skin fibroblasts from sphingolipidosis patients.延迟提取基质辅助激光解吸电离飞行时间质谱在鞘脂贮积症患者培养皮肤成纤维细胞中鞘脂分析中的应用
Brain Dev. 2002 Apr;24(3):170-3. doi: 10.1016/s0387-7604(02)00026-8.
10
[Differential diagnosis of congenital lipidoses by lipid analyses of body fluids, biopsy and autopsy tissue].[通过体液、活检及尸检组织的脂质分析对先天性脂质沉积症进行鉴别诊断]
Fortschr Neurol Psychiatr Grenzgeb. 1975 Nov;43(11):602-17.